Patents by Inventor Wilhelmus Martinus Maria Schaaper

Wilhelmus Martinus Maria Schaaper has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Trisaccharide Derivates, and Their Use as Adjuvants
    Publication number: 20170057987
    Abstract: The present invention relates to the use of trisaccharide derivates comprising a substituted trisaccharide core, which trisaccharide core is fully substituted with fatty acid ester groups, and optionally one or more anionic groups as adjuvants, to the trisaccharide derivates as such, to a method for preparing such trisaccharides, to trisaccharides obtained with such method, to adjuvant compositions comprising such trisaccharide derivates and to a vaccine or kit comprising such adjuvant compositions.
    Type: Application
    Filed: April 5, 2016
    Publication date: March 2, 2017
    Inventors: Johannes Gernardus Mathias Marie Van Bree, Everardus Joannes Peter Maria Schenkelaars, Jouwert Anne Turkstra, Maria Aldegonda Jacoba Kriek, Robert Patrick Hof, Wilhelmus Martinus Maria Schaaper
  • Trisaccharide derivates, and their use as adjuvants
    Patent number: 9327020
    Abstract: The present invention relates to the use of trisaccharide derivates comprising a substituted trisaccharide core, which trisaccharide core is fully substituted with fatty acid ester groups, and optionally one or more anionic groups as adjuvants, to the trisaccharide derivates as such, to a method for preparing such trisaccharides, to trisaccharides obtained with such method, to adjuvant compositions comprising such trisaccharide derivates and to a vaccine or kit comprising such adjuvant compositions.
    Type: Grant
    Filed: June 3, 2011
    Date of Patent: May 3, 2016
    Assignee: Immunovo B.V.
    Inventors: Johannes Gernardus Mathias Marie Van Bree, Everardus Joannes Peter Maria Schenkelaars, Jouwert Anne Turkstra, Maria Aldegonda Jacoba Kriek, Robert Patrick Hof, Wilhelmus Martinus Maria Schaaper
  • HIV Membrane Fusion Inhibitors
    Publication number: 20140357577
    Abstract: The present invention concerns an inhibitor of Human Immunodeficiency Virus (HIV) fusion with, or HIV entry in, a host cell comprising at least 24, but preferably 26, contiguous amino acids; the invention also relates to a pharmaceutical composition comprising said amino acids.
    Type: Application
    Filed: December 18, 2012
    Publication date: December 4, 2014
    Inventors: Bruce Albert Malcolm, Johannes Wilhelmus J. Thuring, Christophe Francis Robert Nestor Buyck, Wim Bert Griet Schepens, Maria Aldegonda Jacoba Kriek, Wilhelmus Martinus Maria Schaaper, Jelle Wouter Slootstra, Peter Timmerman
  • TRISACCHARIDE DERIVATES, AND THEIR USE AS ADJUVANTS
    Publication number: 20130273082
    Abstract: The present invention relates to the use of trisaccharide derivates comprising a substituted trisaccharide core, which trisaccharide core is fully substituted with fatty acid ester groups, and optionally one or more anionic groups as adjuvants, to the trisaccharide derivates as such, to a method for preparing such trisaccharides, to trisaccharides obtained with such method, to adjuvant compositions comprising such trisaccharide derivates and to a vaccine or kit comprising such adjuvant compositions.
    Type: Application
    Filed: June 3, 2011
    Publication date: October 17, 2013
    Applicant: IMMUNOVO B.V.
    Inventors: Johannes Gernardus Mathias Marie Van Bree, Everardus Joannes Peter Maria Schenkelaars, Jouwert Anne Turkstra, Maria Aldegonda Jacoba Kriek, Robert Patrick Hof, Wilhelmus Martinus Maria Schaaper
  • DNA sequences encoding antifungal proteins
    Publication number: 20030226169
    Abstract: The present invention provides DNA sequences encoding antifungal peptides which comprise at least six amino acid residues identical to a run of amino acid residues found between position 21 and position 51 of the Rs-AFP2 antifungal protein sequence (SEQ ID NO: 35) or a substantially homologous protein.
    Type: Application
    Filed: March 13, 2003
    Publication date: December 4, 2003
    Inventors: Aart Van Amerongen, Franky Fant, Frans Alois Melania Borremans, Genoveva Wivina De Samblanx, Lolke Sijtsma, Robbert Hans Meloen, Wouter Cornelis Puijk, Wilhelmus Martinus Maria Schaaper, Willem Frans Broekaert, Wilhelmus Martinus Jozef Van Gelder, Sarah Bronwen Rees
  • Antifungal peptides and composition thereof
    Patent number: 6605698
    Abstract: Antifungal peptides which comprise at least six amino acid residues identical to a run of amino acid residues found between position 21 and position 51 of the Rs-AFP2 antifungal protein sequence or of substantially homologous protein sequences. The peptides are useful for combating fungal diseases in agricultural, pharmaceutical or preservative applications.
    Type: Grant
    Filed: August 7, 1998
    Date of Patent: August 12, 2003
    Assignee: Syngenta Limited
    Inventors: Aart Van Amerongen, Franky Fant, Frans Alois Borremans, Genoveva Wivina De Samblanx, Lolke Sijtsma, Robbert Hans Meloen, Wouter Cornelis Puijk, Wilhelmus Martinus Maria Schaaper, Willem Frans Broekaert, Wilhelmus Martinus Josef van Gelder, Sarah Bronwen Rees